Active strawberry powder for Obesity

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Obesity+1 MoreActive strawberry powder - DietarySupplement
Eligibility
35 - 75
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study the effects of strawberry consumption on adults at high risk for cardiovascular disease and diabetes.

Eligible Conditions
  • Obesity
  • Metabolic Syndrome

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 7 Secondary · Reporting Duration: Week 0, 4, 5, 9, 10, and 14

Week 0
Change in arterial stiffness
Change in blood pressure (resting and 24-hr)
Change in endothelial function
Change in glucose and insulin response
Change in homeostatic model assessment for insulin resistance
Change in inflammation
Change in oxidixed LDL
Change in plasma lipids

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

Mixed active/placebo strawberry powder
1 of 3
Active strawberry powder
1 of 3
Placebo strawberry powder
1 of 3

Active Control

Experimental Treatment

Non-Treatment Group

48 Total Participants · 3 Treatment Groups

Primary Treatment: Active strawberry powder · Has Placebo Group · N/A

Active strawberry powder
DietarySupplement
Experimental Group · 1 Intervention: Active strawberry powder · Intervention Types: DietarySupplement
Placebo strawberry powder
DietarySupplement
PlaceboComparator Group · 1 Intervention: Placebo strawberry powder · Intervention Types: DietarySupplement
Mixed active/placebo strawberry powder
DietarySupplement
ActiveComparator Group · 1 Intervention: Mixed strawberry powder · Intervention Types: DietarySupplement

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: week 0, 4, 5, 9, 10, and 14

Who is running the clinical trial?

Carl Ade, M.S., Ph.D.Lead Sponsor
1 Previous Clinical Trials
60 Total Patients Enrolled
California Strawberry CommissionOTHER
11 Previous Clinical Trials
495 Total Patients Enrolled
2 Trials studying Obesity
109 Patients Enrolled for Obesity
Sara Rosenkranz, PhDPrincipal InvestigatorKansas State University
2 Previous Clinical Trials
87 Total Patients Enrolled
1 Trials studying Obesity
50 Patients Enrolled for Obesity

Eligibility Criteria

Age 35 - 75 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have borderline high LDL-cholesterol.

Who else is applying?

What state do they live in?
Missouri100.0%
How old are they?
65+100.0%
What site did they apply to?
Lafene Health Center100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%

How responsive is this trial?

Typically responds via
Email100.0%
Most responsive sites:
  1. Lafene Health Center: < 24 hours
Average response time
  • < 1 Day